Change Agents Stock (NASDAQ:CHGA)


RevenueFinancialsChart

Previous Close

$2.25

52W Range

$2.15 - $57.98

50D Avg

$4.20

200D Avg

$12.07

Market Cap

$1.62M

Avg Vol (3M)

$207.57K

Beta

-0.04

Div Yield

-

CHGA Company Profile


Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026. Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.

Show More

Industry

Software - Application

Sector

Technology

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Jul 22, 2026

Website

CHGA Performance


CHGA Financial Summary


Dec 25
Revenue-
Operating Income$-7.59M
Net Income$-18.26M
EBITDA$-15.90M
Basic EPS$-5.64
Diluted EPS$-5.64

Fiscal year ends in Dec 25 | Currency in USD